Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II.
Antonijevic
Nebojsa M
NM
Milosevic
Rajko
R
Perunicic
Jovan
J
Stanojevic
Milica
M
Calija
Branko
B
Vasiljevic
Zorana
Z
D000925:Anticoagulants / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D011655:Pulmonary Embolism / Q000139:chemically induced*; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight